Stericycle, Inc. (NASDAQ:SRCL) Shares Sold by M&T Bank Corp

M&T Bank Corp decreased its position in Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 9.8% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 209,854 shares of the business services provider's stock after selling 22,899 shares during the period. M&T Bank Corp owned approximately 0.23% of Stericycle worth $10,400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SRCL. Exchange Traded Concepts LLC raised its stake in shares of Stericycle by 87.5% during the 3rd quarter. Exchange Traded Concepts LLC now owns 1,001 shares of the business services provider's stock valued at $45,000 after buying an additional 467 shares during the last quarter. Stratos Wealth Partners LTD. raised its stake in shares of Stericycle by 4.9% during the 3rd quarter. Stratos Wealth Partners LTD. now owns 13,763 shares of the business services provider's stock valued at $615,000 after buying an additional 640 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Stericycle by 17.3% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,078 shares of the business services provider's stock valued at $808,000 after buying an additional 2,671 shares during the last quarter. Park Avenue Securities LLC purchased a new position in shares of Stericycle during the 3rd quarter valued at about $256,000. Finally, Clarkston Capital Partners LLC raised its stake in shares of Stericycle by 0.8% during the 3rd quarter. Clarkston Capital Partners LLC now owns 6,524,331 shares of the business services provider's stock valued at $291,703,000 after buying an additional 52,087 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. StockNews.com lowered Stericycle from a "buy" rating to a "hold" rating in a research note on Tuesday, April 2nd. Truist Financial dropped their target price on Stericycle from $57.00 to $50.00 and set a "hold" rating on the stock in a research report on Monday, April 29th. Stifel Nicolaus raised their target price on Stericycle from $70.00 to $75.00 and gave the company a "buy" rating in a research report on Thursday, February 29th. Robert W. Baird dropped their target price on Stericycle from $62.00 to $55.00 and set a "neutral" rating on the stock in a research report on Friday, April 26th. Finally, Wells Fargo & Company raised their target price on Stericycle from $40.00 to $48.00 and gave the company an "underweight" rating in a research report on Friday, March 1st. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $59.40.

Stericycle Price Performance

SRCL stock traded up $1.20 during trading on Monday, hitting $47.38. The stock had a trading volume of 444,042 shares, compared to its average volume of 473,611. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.11 and a quick ratio of 1.11. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $57.06. The stock has a market capitalization of $4.40 billion, a P/E ratio of -209.91, a PEG ratio of 2.49 and a beta of 1.12. The company's 50-day moving average price is $50.91 and its two-hundred day moving average price is $48.32.

Stericycle (NASDAQ:SRCL - Get Free Report) last issued its earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.03. The business had revenue of $664.90 million for the quarter, compared to analysts' expectations of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The business's revenue for the quarter was down 2.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.49 EPS. As a group, research analysts predict that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.